The global next-generation sequencing (NGS) services market size
is expected to reach USD 2.87 billion by 2025 at a 13.6% CAGR during the
forecast period, according to a new report by Grand View Research, Inc.
Development of NGS technologies has revolutionized gene sequencing in terms of
reproducibility and cost savings.
This has resulted in introduction of
several advancements in NGS technology to promote its usage in clinical labs
and hospitals. Most current innovations in this field revolve around
simplifying usage of seq-technology and making it more sophisticated. These factors
have driven the uptake of NGS services across various end users.
Conventional disease testing service
providers have broadened their portfolio with a rising trend of seq-based
genetic tests. For example, in October 2014, ARUP Laboratories collaborated
with the Children’s Hospital of Philadelphia (CHOP). The service provision for
NGS-based HLA genotyping, including HLA Class II and HLA Class I, began in
November 2017.
With rising trend of high throughput
sequencing within the pharma and biotech industry, there is a need for more
developments to improve the speed and convenience of high throughput
seq-platforms and simplify workflows. As a result, companies are focusing on
development of solutions to simplify the amplification and purification of
sample and starting input.
In July 2017, Norgen released the new
Small RNA Library Prep Kit for Illumina. This kit is being developed to
generate small RNA libraries and is optimized for samples with low input RNA
(0.5-1ng), such as urine, serum, plasma, cerebral spinal fluid (CSF), blood,
and exosomes.
Browse full research report on Next-Generation Sequencing
(NGS) Services Market: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-services-market
Further key findings from the report suggest:
- Human
genome sequencing services held the largest revenue share owing to greater
penetration of whole genome and whole exome sequencing
- Gene
regulation services, particularly small RNA sequencing and ChIP-seq, is
anticipated to grow at a lucrative pace during the forecast period. Rising
investment in RNA sequencing is driving the growth of gene regulation
services
- Increase
in installation of sequencing platforms is attributive to the larger
revenue share of sequencing services as compared to other workflow steps.
High maintenance and recovery costs of this step have also resulted in
greater revenue generation
- Universities
and other research entities have emerged as prominent end users owing to
growing application of NGS technology for cancer prognosis as well as
diagnosis and major projects taken up by academicians and universities
- North
America dominated the market by revenue in 2017, owing to higher
penetration of the technology in this region and availability of funds to
employ the technique and derive research findings for disease targeting
- Various
prominent players in this market include Illumina, Inc.; Eurofins
Genomics; BGI; and GENEWIZ Germany GmbH. Companies such as GENEWIZ and
Novogene Corporation are engaged in offering NGS services based on
platforms from major NGS developers
- Companies
such as Illumina and BGI, on the other hand, are involved in developing
sequencing instruments and offering services to research entities.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-services-market/request/rs1
Grand View Research has segmented the global next-generation
sequencing services market on the basis of service type, workflow, end use, and
region:
NGS Service Type Outlook (Revenue, USD Million, 2014 - 2025)
- Human
Genome Sequencing
- Single
Cell Sequencing
- Microbial
Genome-based Sequencing
- Gene
Regulation Services
- Small
RNA Sequencing
- ChIP
Sequencing
- Other
Gene Regulation-based Services
- Animal
& Plant Sequencing
- Other
Sequencing Services
NGS Services Workflow Outlook (Revenue, USD Million, 2014 - 2025)
- Pre
Sequencing
- Sequencing
- Data
Analysis
NGS Services End-use Outlook (Revenue, USD Million, 2014 - 2025)
- Universities
& Other Research Entities
- Hospitals
& Clinics
- Pharma
& Biotech Entities
- Others
NGS Services Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment